Baudax Bio Inc. (BXRX)
NASDAQ: BXRX
· Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM
Baudax Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.89M | -7.3M | -7.39M | -9.25M | -29.2M | -7.53M | -12.81M | 29.43M | -16.96M | -15.33M | -16.91M |
Depreciation & Amortization | 131K | 1K | 3K | 105K | 683K | 687K | 687K | 689K | 690K | 707K | 730K |
Stock-Based Compensation | 253K | 198K | 191K | 229K | 314K | 337K | 521K | 657K | 925K | 903K | 2.3M |
Other Working Capital | -256K | -147K | -749K | 105K | 596K | 1.02M | -287K | -553K | -55K | 756K | 773K |
Other Non-Cash Items | -220K | 206K | 1.75M | 5.73M | 23.68M | 1.56M | -3.58M | -42.64M | 4.04M | 4.11M | 2.07M |
Deferred Income Tax | -3.63M | 2.8M | n/a | n/a | n/a | n/a | n/a | -11K | -6K | -1.61M | 18K |
Change in Working Capital | 2.94M | 654K | 777K | -594K | 645K | -2.27M | 2.28M | -776K | -1.26M | 1.17M | -2.21M |
Operating Cash Flow | -2.41M | -3.45M | -4.66M | -3.78M | -3.89M | -7.22M | -12.9M | -12.65M | -12.57M | -10.05M | -14.01M |
Capital Expenditures | n/a | n/a | n/a | 40K | -20K | -20K | -20K | -127K | n/a | -3K | -73K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.49M | -4.65M | -7.5M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.15M | n/a | n/a | n/a |
Other Investing Acitivies | -21K | 142K | n/a | n/a | n/a | n/a | n/a | n/a | 9.5M | n/a | n/a |
Investing Cash Flow | -21K | 142K | n/a | 40K | -20K | -20K | -20K | 10.02M | 2.01M | -4.66M | -7.57M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -15K | 13K | -1K | n/a | -13K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.38M | 917K | 3.21M | 3.4M | 4.33M | 902K | 8.56M | 3.74M | -78K | 9.43M | 21.92M |
Financial Cash Flow | 1.38M | 917K | 3.21M | 3.4M | 4.33M | 902K | 8.56M | 3.74M | -78K | 9.43M | 21.92M |
Net Cash Flow | -1.05M | -2.39M | -1.46M | -388K | 437K | -6.32M | -4.36M | 1.12M | -10.64M | -5.28M | 348K |
Free Cash Flow | -2.41M | -3.45M | -4.66M | -3.74M | -3.91M | -7.24M | -12.92M | -12.77M | -12.57M | -10.05M | -14.08M |